Trinity Biotech PLC (TRIB) - NASDAQ
  • Apr. 30, 2015, 9:24 AM
    • Trinity Biotech (NASDAQ:TRIB) declares $0.22/share annual dividend, in line with previous.
    • Forward yield 1.31%
    • Payable June 30; for shareholders of record June 9; ex-div June 5.
    | Apr. 30, 2015, 9:24 AM
  • Apr. 25, 2013, 1:58 PM
    Trinity Biotech (TRIB) The board propose to increase annual dividend to $0.20/ADR, 33% increase from prior dividend of $0.15. The increased dividend represents an annual yield of 1.24%. (PR)
    | Apr. 25, 2013, 1:58 PM
Company Description
Trinity Biotech Plc develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. Its products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the... More
Sector: Healthcare
Industry: Diagnostic Substances
Country: Ireland